Skip to main content
NIH Clinical Center: National Institutes of Health
Search the NIH Clinical Center
  Clinical Center Home | Contact Us | Site Map
About the Clinical Center
For Researchers and Physicians
Participate in Clinical Studies

 
 

Course-Specific Elements


Principles of Clinical Pharmacology: Schedule/Syllabus

All sessions will meet Thursday evenings from 6:30 p.m. to approximately 7:45 p.m. Eastern time in the NIH Clinical Center, Building 10, in the Lipsett Amphitheater in Bethesda, Maryland.

If you experience any accessibility problems with the PDFs below, please contact (301) 496-9425 or email CC-OD_Clinp@mail.cc.nih.gov

September 4

Introduction to course

Introduction Slides (1 slide per page)PDF Logo
Introduction Slides (3 slides per page)PDF Logo
Introduction Slides (Text-Only)PDF Logo

Video of Introduction to course from previous year lecture with caption Real Player Icon

 

J. Lertora
(NIH/CC)

MODULE 1: PHARMACOKINETICS

September 11

Clinical pharmacokinetics

Clinical Pharmacokinetics Slides (1 slide per page)PDF Logo
Clinical Pharmacokinetics Slides (3 slides per page)PDF Logo
Clinical Pharmacokinetics Slides (Text-Only) PDF Logo

Video of Clinical pharmacokinetics from previous year lecture with caption Real Player Icon

 J. Lertora
(NIH/CC)

September 18

Chemical assay of drugs and drug metabolites

Chemical Assay Slides (1 slide per page)PDF Logo
Chemical Assay Slides (3 slides per page)PDF Logo
Chemical Assay Slides (Text-Only)PDF Logo

Video of Chemical assay of drugs and drug metabolites from previous year lecture with caption Real Player Icon

S. Markey
(NIH/NIMH)

September 25

Compartmental analysis of drug distribution

Compartmental analysis of drug distribution slides (1 slide per page)PDF Logo
Compartmental analysis of drug distribution slides (3 slides per page)PDF Logo
Compartmental analysis of drug distribution slides (Text-Only)PDF Logo

Video of compartmental analysis of drug distribution from previous year lecture with caption Real Player Icon

J. Lertora
(NIH/CC)

October 2

Drug absorption and bioavailability

Drug absorption and bioavailability slides (1 slide per page)PDF Logo
Drug absorption and bioavailability slides (3 slides per page)PDF Logo
Drug absorption and bioavailabilityslides (Text-Only)PDF Logo

Guidance for Industry:  Waiver of In Vivo Bioavailability and Bioequivalence Studies for Immediate-Release Solid Oral Dosage Forms Based on Biopharmaceutics Classification Sytem. 
Video of drug absorption and bioavailability from previous year lecture with caption Real Player Icon

J. Lertora
(NIH/CC)

October 9

Use of positron emission tomography (PET) in pharmacokinetics 

Positron Emission Tomography slides (1 slide per page)PDF Logo
Positron Emission Tomography slides (3 slides per page)PDF Logo
Positron Emission Tomography slides (Text-Only)PDF Logo

Video of Positron emission tomography (PET) from previous year lecture with caption Real Player Icon

PET from previous year Lecture -Video 1 Real Player Icon
PET from previous year Lecture -Video 2  Real Player Icon

R. Innis
(NIH/NIMH)

October 16

Effects of renal disease on pharmacokinetics

Effects of renal disease on pharmacokinetics (1 slide per page)PDF Logo
Effects of renal disease on pharmacokinetics (3 slides per page)PDF Logo
Effects of renal disease on pharmacokinetics (Text-Only)PDF Logo

Video of Effects of Renal Disease on Pharmacokinetics with caption Real Player Icon

J. Lertora
(NIH/CC)

October 23

SPECIAL LECTURE: Pharmacokinetics in patients requiring renal replacement therapy

Video of pharmacokinetics in patients requiring hemodialysis from previous year lecture Video with caption Real Player Icon

Supplemental Reading:
FDA Guidance for Industry: Pharmacokinetics in Patients with Impaired Renal Function –
Study Design, Data Analysis, and Impact on Dosing and Labeling.
http://www.fda.gov/cder/guidance/1449fnl.pdf PDF Logo

A. Atkinson
(Northwestern University)

G. Susla
(MedImmune, Inc)

October 30 

Noncompartmental vs. compartmental approaches to PK analysis

Noncompartmental vs. compartmental approaches to PK analysis (1 slide per page)PDF Logo
Noncompartmental vs. compartmental approaches to PK analysis (3 slides per page)PDF Logo
Noncompartmental vs. compartmental approaches to PK analysis (Text-only)PDF Logo

Video of noncompartmental vs. compartmental approaches to PK data analysis with caption Real Player Icon

P. Vicini
(Pfizer, Inc.)

November 6

Effects of liver disease on pharmacokinetics

Effects of liver disease on pharmacokinetics (1 slide per page)PDF Logo
Effects of liver disease on pharmacokinetics (3 slides per page)PDF Logo
Effects of liver disease on pharmacokinetics (Text-only)PDF Logo

Supplemental Reading:
FDA Guidance for Industry: Pharmacokinetics in Patients with Impaired Hepatic Function: Study Design, Data Analysis, and Impact on Dosing and Labeling.
http://www.fda.gov/cber/gdlns/imphep.pdf PDF Logo

Video of effects of liver disease on pharmacokinetics from previous year lecture video with caption Real Player Icon

J. Lertora
(NIH/CC)

November 13

Population pharmacokinetics

Population pharmacokinetics (1 slide per page)PDF Logo
Population pharmacokinetics (3 slides per page)PDF Logo
Population pharmacokinetics (Text-only)PDF Logo

Video of population pharmacokinetics from previous year video with caption Real Player Icon

R. Miller
(Pfizer, Inc.)

MODULE 2: DRUG METABOLISM AND TRANSPORT

November 20

Pathways of drug metabolism

Pathways of drug metabolism (1 slide per page)PDF Logo
Pathways of drug metabolism (3 slides per page)PDF Logo
Pathways of drug metabolism (Text-only)PDF Logo

Video of pathways of drug metabolism from previous year lecture video with caption Real Player Icon

S. Markey
(NIH/NIMH)

December 4

Pharmacogenomics

Pharmacogenomics (1slide per page) PDF Logo
Pharmacogenomics (3 slides per page)PDF Logo
Pharmacogenomics (Text-only)PDF Logo

Video of pharmacogenetics from previous year lecture video with caption Real Player Icon 

D. Flockhart
(IUPUI)

December 11

Drug Interactions

Drug Interactions (1 slide per page)PDF Logo
Drug Interactions (3 slides per page)PDF Logo
Drug Interactions (Text-only) PDF Logo

Video of drug interactions from previous year lecture video with caption Real Player Icon 

S. Penzak
(NIH/CC)

December 18

Biochemical mechanisms of drug toxicity

Biochemical mechanisms of drug toxicity (1 slide per page)PDF Logo
Biochemical mechanisms of drug toxicity (3 slides per page)PDF Logo
Biochemical mechanisms of drug toxicity (Text-only)PDF Logo

Video of Biochemical mechanisms of drug toxicity from previous year lecture video with caption Real Player Icon

L. Pohl
(NIH/NHLBI)

January 8

Equilibrative and concentrative transport

Equilibrative and concentrative transport (1 slide per page)PDF Logo
Equilibrative and concentrative transport (3 slides per page) PDF Logo
Equilibrative and concentrative transport (Text-only)PDF Logo
Video of Equilibrative and concentrative transport from previous year lecture video with caption Real Player Icon

J. Ware
(Genentech, Inc.)

January 15

SPECIAL LECTURE: P-glycoprotein and drug transport

Dr. Innis's slides from previous year lecture PDF Logo
Dr. Gottesman's slides from previous year lecture PDF Logo

Video of P-glycoprotein and drug transport from previous year lecture video with caption Real Player Icon

M. Gottesman
(NIH/OIR)

R. Innis
(NIH/NIMH)

MODULE 3: ASSESSMENT OF DRUG EFFECTS:

January 22

Dose response and concentration response analysis

Slides of Dose response and concentration response analysis from previous year lecture PDF Logo

Video of Dose response and concentration response analysis from previous year lecture video with caption Real Player Icon

F. Balis
(NIH/NCI)

January 29

Disease progression models and clinical trial simulation

Slides of disease progression models and clinical trial simulation from previous year lecture PDF Logo

Video of disease progression models and clinical trial simulation from previous year lecture Real Player Icon

D. Mould
(Projections Research, Inc.)

February 5

Physiological and laboratory markers of drug effect

Slides of physiological and laboratory markers of drug effect from previous year lecture PDF Logo

Video of physiological and laboratory markers of drug effect from previous year lecture video with captionReal Player Icon 

J. Woodcock
(FDA)

MODULE 4: Optimizing and Evaluating Patient Therapy

February 12

Drug therapy in pregnant and nursing women

Slides of drug therapy in pregnant and nursing women from previous year lecture PDF Logo

Video of drug therapy in pregnant and nursing women from previous year lecture Real Player Icon

M. Frederiksen
(Northwestern University)

February 19

Developmental and pediatric pharmacology

Slides of developmental and pediatric pharmacology from previous year lecture PDF Logo

Video of developmental and pediatric pharmacology previous year lecture video with caption Real Player Icon

F. Balis
(NIH/NCI)

February 26

Drug therapy in the elderly

Slides of drug therapy in the elderly previous year lecture PDF Logo

Video of drug therapy in the elderly previous year lecture video with caption Real Player Icon

D. Abernethy
(U.S. Pharmacopeia)

March 5

Quality assessment of drug therapy

Slides of quality assessment of drug therapy previous year lecture video with caption PDF Logo

Video of quality assessment of drug therapy previous year lecture video with caption 

C. Daniels
(UCSD)

March 12

Clinical analysis of adverse drug reactions

Slides of clinical analysis of adverse drug reactions previous year lecture PDF Logo

Video of clinical analysis of adverse drug reactions previous year lecture video with caption Real Player Icon

K. Calis
(NIH/CC)

 

MODULE 5: DRUG DISCOVERY AND DEVELOPMENT

March 19

Drug discovery

Slides of drug discovery previous year lecture PDF Logo

Video of drug discovery previous year lecture video with caption Real Player Icon

E. Sausville
(UMMS)

March 26

Pre-clinical drug development

Slides of pre-clinical drug development previous year lecture PDF Icon

Video of pre-clinical drug development previous year lecture video with caption Real Player Icon

C. Takimoto
(Centocor R&D, Inc., Johnson & Johnson)

April 2

Animal scale up and Phase I studies

Dedrick Slides for Animal scale up and Phase I studies previous year lecture PDF Icon

Collins Slides for Animal scale up and Phase I studies previous year lecture PDF Icon


Animal scale up and Phase I studies from previous PCP course PDF Icon

Dr. Dedrick's previous year lecture Video with caption Real Player Icon

Dr. Collins' previous year lecture Video with caption Real Player Icon

R. Dedrick
(NIH/NIBIB)

J. Collins
(NIH/NCI)

April 9

Pharmacokinetics of biotechnology products and large molecules

Slides of pharmacokinetics of biotechnology products and large molecules from previous year lecture PDF Icon

Video of pharmacokinetics of biotechnology products and large molecules from previous year lecture video with caption Real Player Icon

P. Garzone
(PD3G Consulting) 

April 16

Design of clinical drug development programs

Slides of design of clinical drug development program from previous year lecture PDF Icon

Video of design of clinical drug development program from previous year video with caption Real Player Icon

C. Grudzinskas
(NDA Partners, LLC and
CDDS, UCSF)

April 23

Role of the FDA in guiding drug development

Slides of role of the FDA in guiding drug development previous year lecture PDF Icon

Video of role of the FDA in guiding drug development from previous year lecture video with caption Real Player Icon

C. Peck
(CDDS, UCSF)


NOTE: PDF documents require the free Adobe Reader.
Video requires RealPlayer software and high-speed internet connection.

This page last reviewed on 01/8/09

Privacy Statement | Accessibility | FOIA | Disclaimer
NIH Clinical Center | National Institutes of Health | Department of Health and Human Services

Clinical Center        National Institutes of Health        Department of Health and Human Services        USA Gov